Tubastatin A对猪心肺复苏后肾及肠损伤的保护作用及机制
该研究将25头健康雄性白猪随机分为假手术组(n=6)、CPR模型组(n=10)和TubA干预组(n=9),采用右心室电刺激诱导9分钟心脏骤停后行6分钟CPR建立猪CPR模型。TubA干预组在复苏成功后5分钟经股静脉输注4.5 mg/kg TubA,1小时内输完;假手术组和CPR模型组输注等量生理盐水。结果显示,与CPR模型组相比,TubA干预组复苏后1小时SCr和DAO、2小时BUN、4小时I-FABP均显著降低(均P<0.05),24小时肾和肠凋亡指数及RIP3、MLKL表达水平显著降低(均P<0.05)。作者认为TubA对减轻复苏后肾功能障碍和肠黏膜损伤具有保护作用,其机制可能与抑制细胞凋亡和坏死性凋亡有关。
要点
- 猪CPR模型中,复苏成功后5分钟经股静脉1小时内输注TubA 4.5 mg/kg,可降低复苏后1小时SCr(87±6 vs. 122±7 μmol/L)和DAO(8.1±1.2 vs. 10.3±0.8 kU/L),均P<0.05。
- TubA干预组复苏后2小时BUN(12.3±1.2 vs. 14.7±1.3 mmol/L)、4小时I-FABP(661±39 vs. 751±38 ng/L)显著低于CPR模型组,均P<0.05。
- TubA干预组复苏后24小时肾凋亡指数(21.4±4.6)% vs. CPR模型组(55.2±9.5)%、肠凋亡指数(21.3±4.5)% vs.(50.9±7.0)%,均P<0.05。
- TubA干预组复苏后24小时肾组织RIP3蛋白(RIP3/GAPDH)1.11±0.07 vs. 1.39±0.17、MLKL蛋白(MLKL/GAPDH)1.20±0.14 vs. 1.51±0.26,肠组织RIP3蛋白1.24±0.18 vs. 1.69±0.28、MLKL蛋白1.38±0.15 vs. 1.80±0.26,均P<0.05。
- 作者认为TubA对减轻复苏后肾功能障碍和肠黏膜损伤具有保护作用,其机制可能与抑制细胞凋亡和坏死性凋亡有关。
适用人群与场景
- 健康雄性白猪,采用右心室电刺激诱导9分钟心脏骤停后行6分钟CPR建立CPR模型。
- 假手术组仅行气管插管、置管和麻醉监测等常规操作。
处置流程与药物剂量
- TubA干预组在复苏成功后5分钟经股静脉输注TubA 4.5 mg/kg,1小时内输完。
- 假手术组和CPR模型组输注等量生理盐水。
- 建模前及复苏后1、2、4、24小时采集静脉血,用ELISA测定血清SCr、BUN、I-FABP和DAO水平。
- 复苏后24小时取左肾上极和回肠末端组织,用TUNEL检测细胞凋亡,用Western blotting检测RIP3和MLKL表达水平。
研究设计与关键结果
- 研究类型为动物实验,25头健康雄性白猪随机分为假手术组(n=6)、CPR模型组(n=10)和TubA干预组(n=9)。
- 与假手术组相比,CPR模型组和TubA干预组复苏后出现肾功能障碍和肠黏膜损伤,表现为血清SCr、BUN、I-FABP和DAO水平显著升高。
- 与CPR模型组相比,TubA干预组复苏后1小时SCr(μmol/L)87±6 vs. 122±7、1小时DAO(kU/L)8.1±1.2 vs. 10.3±0.8、2小时BUN(mmol/L)12.3±1.2 vs. 14.7±1.3、4小时I-FABP(ng/L)661±39 vs. 751±38,均P<0.05。
- 与假手术组相比,CPR模型组和TubA干预组复苏后24小时肾和肠细胞凋亡及坏死性凋亡显著增加,表现为凋亡指数和RIP3、MLKL表达水平显著升高。
- 与CPR模型组相比,TubA干预组复苏后24小时肾凋亡指数(21.4±4.6)% vs.(55.2±9.5)%、肠凋亡指数(21.3±4.5)% vs.(50.9±7.0)%,均P<0.05;肾组织RIP3蛋白(RIP3/GAPDH)1.11±0.07 vs. 1.39±0.17、MLKL蛋白(MLKL/GAPDH)1.20±0.14 vs. 1.51±0.26,肠组织RIP3蛋白(RIP3/GAPDH)1.24±0.18 vs. 1.69±0.28、MLKL蛋白(MLKL/GAPDH)1.38±0.15 vs. 1.80±0.26,均P<0.05。
证据类型、等级与局限
- 证据类型:动物实验(猪CPR模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为TubA对减轻复苏后肾功能障碍和肠黏膜损伤具有保护作用,其机制可能与抑制细胞凋亡和坏死性凋亡有关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the protective effect and potential mechanism of tubastatin A (TubA), a specific inhibitor of histone deacetylase 6 (HDAC6), on renal and intestinal injuries after cardiopulmonary resuscitation (CPR) in swine.
METHODS: Twenty-five healthy male white swine were divided into Sham group (n = 6), CPR model group (n = 10) and TubA intervention group (n = 9) using a random number table. The porcine model of CPR was reproduced by 9-minute cardiac arrest induced by electrical stimulation via right ventricle followed by 6-minute CPR. The animals in the Sham group only underwent the regular operation including endotracheal intubation, catheterization, and anesthetic monitoring. At 5 minutes after successful resuscitation, a dose of 4.5 mg/kg of TubA was infused via the femoral vein within 1 hour in the TubA intervention group. The same volume of normal saline was infused in the Sham and CPR model groups. Venous samples were collected before modeling and 1, 2, 4, 24 hours after resuscitation, and the levels of serum creatinine (SCr), blood urea nitrogen (BUN), intestinal fatty acid binding protein (I-FABP) and diamine oxidase (DAO) in serum were determined by enzyme-linked immunoadsordent assay (ELISA). At 24 hours after resuscitation, the upper pole of left kidney and terminal ileum were harvested to detect cell apoptosis by TdT-mediated dUTP-biotin nick end labeling (TUNEL), and the expression levels of receptor-interacting protein 3 (RIP3) and mixed lineage kinase domain-like protein (MLKL) were detected by Western blotting.
RESULTS: After resuscitation, renal dysfunction and intestinal mucous injury were observed in the CPR model and TubA intervention groups when compared with the Sham group, which was indicated by significantly increased levels of SCr, BUN, I-FABP and DAO in serum. However, the serum levels of SCr and DAO starting 1 hour after resuscitation, the serum levels of BUN starting 2 hours after resuscitation, and the serum levels of I-FABP starting 4 hours after resuscitation were significantly decreased in the TubA intervention group when compared with the CPR model group [1-hour SCr (μmol/L): 87±6 vs. 122±7, 1-hour DAO (kU/L): 8.1±1.2 vs. 10.3±0.8, 2-hour BUN (mmol/L): 12.3±1.2 vs. 14.7±1.3, 4-hour I-FABP (ng/L): 661±39 vs. 751±38, all P < 0.05]. The detection of tissue samples indicated that cell apoptosis and necroptosis in the kidney and intestine at 24 hours after resuscitation were significantly greater in the CPR model and TubA intervention groups when compared with the Sham group, which were indicated by significantly increased apoptotic index and markedly elevated expression levels of RIP3 and MLKL. Nevertheless, compared with the CPR model group, renal and intestinal apoptotic indexes at 24 hours after resuscitation in the TubA intervention group were significantly decreased [renal apoptosis index: (21.4±4.6)% vs. (55.2±9.5)%, intestinal apoptosis index: (21.3±4.5)% vs. (50.9±7.0)%, both P < 0.05], and the expression levels of RIP3 and MLKL were significantly reduced [renal tissue: RIP3 protein (RIP3/GAPDH) was 1.11±0.07 vs. 1.39±0.17, MLKL protein (MLKL/GAPDH) was 1.20±0.14 vs. 1.51±0.26; intestinal tissue: RIP3 protein (RIP3/GAPDH) was 1.24±0.18 vs. 1.69±0.28, MLKL protein (MLKL/GAPDH) was 1.38±0.15 vs. 1.80±0.26, all P < 0.05].
CONCLUSIONS: TubA has the protective effect on alleviating post-resuscitation renal dysfunction and intestinal mucous injury, and its mechanism may be related to inhibition of cell apoptosis and necroptosis.
参考来源
- Wu X, Zhao X, Chen Q, et al. [Protective role and mechanism of tubastatin A on renal and intestinal injuries after cardiopulmonary resuscitation in swine]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37308196. doi:10.3760/cma.j.cn121430-20220907-00825
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。